Better Therapeutics, Inc.

Better Therapeutics, Inc. is the post-merger operating company that resulted from its business combination with Mountain Crest Acquisition Corp. II, a blank-check company that traded on Nasdaq under the ticker MCAD and completed its initial public offering in 2021. The SPAC was sponsored by Mountain Crest Capital LLC and targeted the healthcare technology sector, ultimately combining with Better Therapeutics, a prescription digital therapeutics developer whose pipeline centers on cardiometabolic diseases including Type 2 diabetes and hypertension. The company filed this 8-K current report with the Securities and Exchange Commission on June 8, 2023, disclosing a material corporate event in its post-merger operational phase. Sign up for SpacDesk to access the complete filing history, deal timeline, and real-time data on Better Therapeutics and thousands of other SPAC transactions.